Drug Shortage Report for MULTIHANCE

Last updated on 2025-03-17 History
Report ID 246225
Drug Identification Number 02248302
Brand name MULTIHANCE
Common or Proper name Gadobenate Dimeglumine injection
Company Name BRACCO IMAGING CANADA
Market Status MARKETED
Active Ingredient(s) GADOBENATE DIMEGLUMINE
Strength(s) 529MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5ml, 10ml,15ml, 20ml, 50ml
ATC code V08CA
ATC description MAGNETIC RESONANCE IMAGING CONTRAST MEDIA
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-12-17
Estimated end date 2025-02-14
Actual end date 2025-02-14
Shortage status Resolved
Updated date 2025-03-17
Company comments The manufacturing and release of the product at the approved manufacturing site are suspended until issue is identified and resolved.
Health Canada comments
Tier 3 Status No
Contact Address 11065 BOUL. L-H LAFONTAINE
VILLE D'ANJOU, QUEBEC
CANADA H1J 2Z4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2025-03-17 French Compare
v8 2025-03-17 English Compare
v7 2025-03-13 French Compare
v6 2025-03-13 English Compare
v5 2025-01-09 French Compare
v4 2025-01-09 English Compare
v3 2024-12-20 French Compare
v2 2024-12-20 English Compare
v1 2024-12-20 English Compare

Showing 1 to 9 of 9